Trade GRCE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Grace Therapeutics, Inc. (GRCE) is trading at US$2.11, down 0.94% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$46.28M. Over the past 52 weeks, GRCE has traded between US$1.79 and US$5.18. On Syfe you can trade GRCE with $0 commission and add it to your watchlist.
| Previous close | US$2.13 |
|---|---|
| Market cap | US$46.28M |
| 52-week range | US$1.79 – US$5.18 |
| Volume | 83.02K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Grace Therapeutics, Inc.
Grace Therapeutics, Inc. engages in the development and commercialization of drug candidates for rare and orphan diseases. It focuses on utilizing proprietary technologies to improve the performance of currently marketed drugs. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Year: 2011
Sector Update: Health Care Stocks Edge Lower Late Afternoon
Apr 23, 7:51 PM · MT Newswires
Sector Update: Health Care
Apr 23, 7:26 PM · MT Newswires
Grace Therapeutics Gets FDA Complete Response Letter for GTx-104
Apr 23, 5:43 PM · MT Newswires
Grace Therapeutics, Inc. (GRCE) stock is trading at US$2.11, -0.94% from the previous close of US$2.13.
The market cap for Grace Therapeutics, Inc. (GRCE) stock is approximately US$46.28M.
The 52-week high for Grace Therapeutics, Inc. (GRCE) stock is US$5.18.
The 52-week low for Grace Therapeutics, Inc. (GRCE) stock is US$1.79.
Grace Therapeutics, Inc. (GRCE) does not currently pay a dividend.
Stay on top of GRCE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
